Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Acute myeloid leukemia
Core binding factor acute myeloid leukemia
An acute myeloid leukemia that is characterized by the presence of t(8;21)(q22;q22) or inv(16)(p13q22)/t(16;16)(p13;q22). These cytogenetic abnormalities result in disruption of the transcription factor CBF, which is a regulator of normal hematopoiesis.
This condition has no sub-types.